Asset Details
Do you wish to reserve the book?
Cardiovascular alterations do exist in children with stage-2 chronic kidney disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cardiovascular alterations do exist in children with stage-2 chronic kidney disease
Do you wish to request the book?
Cardiovascular alterations do exist in children with stage-2 chronic kidney disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cardiovascular alterations do exist in children with stage-2 chronic kidney disease
2016
Overview
Background
Cardiovascular disease (CVD) is an important complication of chronic kidney disease (CKD) in children. However, it is not well known when and how cardiovascular alterations start.
Methods
This cross-sectional, controlled study consisted of 25 patients and 28 healthy controls. 24-h ambulatory blood pressure monitoring, aortic pulse wave velocity (aPWV), carotid intima-media thickness (cIMT) and carotid distensibility (distensibility coefficient and
β
stiffness index), and echocardiography were assessed to evaluate CVD. Routine biochemical parameters, fibroblast growth factor-23 (FGF23) and high sensitive C- reactive protein were measured to determine cardiovascular risk factors.
Results
Hypertension was found in 12 patients (48 %). Patients had higher FGF23 levels and aPWV-standard deviation score (SDS) as compared to the controls (
p
= 0.003 and
p
= 0.002, respectively). Aortic PWV-SDS was predicted by increased daytime systolic blood pressure load (
β
= 0.512,
p
= 0.009,
R
2
= 0.262). Neither cIMT nor distensibility differed between the groups; however, older age and high level of FGF23 were independent predictors of
β
stiffness index in patients (
β
= 0.507,
p
= 0.005,
R
2
= 0.461 and
β
= 0.502,
p
= 0.005,
R
2
= 0.461, respectively). As compared to controls, patients had worse left ventricular diastolic function [lower E/A ratio
p
= 0.006) and increased left atrial dimension (
p
< 0.001)].
Conclusions
Cardiovascular deteriorations appear in children with stage-2 CKD. Good control of BP and decreasing the level of FGF23 may be useful to slow down the progression of cardiovascular complications.
Publisher
Springer Japan,Springer Nature B.V
Subject
